Stocks in play: Custom Health Holdings Inc.
Announced its consolidated financial results for the fiscal first quarter ended March 31, 2026. For ...
Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026
For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million, reflecting...
Custom Health Announces Strategic Leadership Appointments to Support Continued Growth and Regulatory Excellence
Robert Guzman has been appointed Chief Compliance & Regulatory Officer, bringing extensive experience in regulatory oversight, compliance management, and quality assurance to strengthen Custom Health's...